Clinical Trial Update: Trial of Acetylsalicylic Acid and Atorvastatin in Patients With Castrate-resistant Prostate Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial update for acetylsalicylic acid (aspirin) and atorvastatin in patients with castration-resistant prostate cancer; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• Aspirin (Aspirin)
• Lipitor (atorvastatin)

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: Prostate Cancer | Phase 3 | Status: RECRUITING